Cellino Bio
Cellino Bio is a Boston-area biotechnology company developing AI-driven optical bioprocessing to manufacture personalized, autologous regenerative medicines from a patient's own induced pluripotent stem cells (iPSC). Its proprietary Nebula platform combines deep learning, laser-based cell management, and closed-loop optical bioprocesses to produce living therapeutics targeting degenerative conditions such as kidney disease, lung disease, spinal cord injury, Alzheimer's, diabetes, and obesity. The company also operates Cellinoverse, a digital simulation environment for its manufacturing workflows. Backed by 8vc. This profile is maintained in the API Evangelist network; Cellino Bio publishes no public developer API, documentation, or developer portal at this time.
Cellino Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Regenerative Medicine, Stem Cells, and Artificial Intelligence.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API